211 – 220 of 1740
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo-controlled crossover trial
(
- Contribution to journal › Article
-
Mark
The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening
(
- Contribution to journal › Article
-
Mark
Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease
(
- Contribution to journal › Article
-
Mark
Prevalence and severity of differing dimensions of breathlessness among elderly males in the population
(
- Contribution to journal › Article
-
Mark
Agreement of the modified Medical Research Council and New York Heart Association scales for assessing the impact of self-rated breathlessness in cardiopulmonary disease
(
- Contribution to journal › Article
-
Mark
Emphysema severity index (ESI) associated with respiratory death in a large Swedish general population
(
- Contribution to journal › Article
-
Mark
Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
-
Mark
The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)
(
- Contribution to journal › Article
-
Mark
The effect of the COVID-19 pandemic on severe asthma care in Europe: Will care change for good?
(
- Contribution to journal › Article
-
Mark
Minimally Clinically Important Improvements (MCII) and Worsening (MCIW) in Symptoms
(
- Contribution to journal › Letter